News

Two topics critical to the future of cancer care and research—and central to ASCO's mission—were the focus of a pair of oncology podcasts that dropped in April. The NRG Oncology podcast, released on ...
Members of the Association for Clinical Oncology (ASCO) were on Capitol Hill on April 8, 2025, for the 10th annual ASCO Advocacy Summit, where they met with lawmakers to discuss critical issues in ...
The following is a message from the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur: On April 11, 2025, the Food and Drug Administration approved nivolumab (Opdivo, Bristol Myers ...
The U.S. Supreme Court issued an opinion on Wednesday, April 2, that the Food and Drug Administration (FDA) was within its power to regulate the sale of certain flavored e-cigarette products. The case ...
Explore resources for getting to Chicago and navigating the ASCO Annual Meeting online and in-person.
Formerly the JCO Journals Lounge, JCO Central is a place of community for oncology authors, researchers, or anyone interested in publishing. Meet with JCO Journals editors and discuss manuscript ...
Start planning before you arrive at McCormick Place. View the information below so you know where to go for all of your needs while you’re at the Meeting, including onsite childcare and accessibility ...
Learn more about abstract submission, policies, and guidelines for faculty and presenters.
ASCO understands the importance of making connections, sharing ideas, and establishing the foundation for future collaborations, and we're so excited to give you the chance to connect onsite. At ...
#ASCO25 will feature nearly 250 oral abstract presentations across Oral Abstract Sessions, Clinical Science Symposia, and the ASCO Plenary Session. Rapid Oral Abstract sessions will also provide over ...
Please review the following abstract policies when preparing your submission. You can also review the Abstract Policy FAQs page for answers to common questions asked by submitters.
View meeting statistics and demographic information for the 2024 Annual Meeting.